Laboratory of Clinical Neurophysiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Biol Blood Marrow Transplant. 2020 Sep;26(9):1738-1746. doi: 10.1016/j.bbmt.2020.05.011. Epub 2020 May 21.
Accumulating evidence points toward a protective role of intestinal microbiota diversity in allogeneic hematopoietic cell transplantation (allo-HCT). The purpose of this systematic review and meta-analysis is to determine the effect of antibiotic-mediated disruption of microbiota on main allo-HCT outcomes (graft-versus-host disease [GVHD], treatment-related mortality [TRM], overall survival [OS]). Following literature search, 2 reviewers screened eligible studies and assessed risk of bias (RoB). Meta-analysis was performed using Review Manager Software. Among 443 screened references, 18 were eligible for meta-analysis. In studies with genomic markers, grade II to IV acute GVHD was significantly reduced in patients not receiving gut decontamination (GD) (odds ratio [OR], 1.56; 95% confidence interval [CI], 1.20 to 2.04). In subgroup analysis, prophylaxis with systemic antibiotics conferred an increased risk of acute GVHD (OR, 1.65; 95% CI, 1.08 to 2.53). When we incorporated RoB, we found a positive correlation of intestinal GVHD with GD (OR, 1.77; 95% CI, 1.29 to 2.44). Patients with higher microbiota diversity presented increased OS (risk ratio [RR], 1.58; 95% CI, 1.19 to 2.09) and lower TRM (RR, 0.45; 95% CI, 0.26 to 0.76). Our findings confirm that GD and prophylaxis with systemic antibiotics increase acute and intestinal GVHD. Importantly, our meta-analysis was the first to show a significant effect of microbiota diversity on TRM and OS.
越来越多的证据表明,肠道微生物多样性在异基因造血细胞移植(allo-HCT)中具有保护作用。本系统评价和荟萃分析的目的是确定抗生素介导的微生物群破坏对主要 allo-HCT 结局(移植物抗宿主病 [GVHD]、治疗相关死亡率 [TRM]、总生存率 [OS])的影响。在文献检索后,2 名审查员筛选了合格的研究并评估了偏倚风险(RoB)。使用 Review Manager 软件进行荟萃分析。在筛选出的 443 篇参考文献中,有 18 篇符合荟萃分析条件。在具有基因组标志物的研究中,未接受肠道去污(GD)的患者中,II 级至 IV 级急性 GVHD 的发生率显著降低(比值比 [OR],1.56;95%置信区间 [CI],1.20 至 2.04)。在亚组分析中,全身使用抗生素预防可增加急性 GVHD 的风险(OR,1.65;95% CI,1.08 至 2.53)。当我们纳入 RoB 时,我们发现肠道 GVHD 与 GD 呈正相关(OR,1.77;95% CI,1.29 至 2.44)。具有更高微生物多样性的患者具有更高的 OS(风险比 [RR],1.58;95% CI,1.19 至 2.09)和更低的 TRM(RR,0.45;95% CI,0.26 至 0.76)。我们的研究结果证实,GD 和全身使用抗生素预防可增加急性和肠道 GVHD。重要的是,我们的荟萃分析首次表明微生物多样性对 TRM 和 OS 有显著影响。